Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Virtual Congress 2020

Bristol Myers Squibb - The role of immuno-oncology in the evolving treatment landscapes of upper GI cancers

The role of immuno-oncology in the evolving treatment landscapes of upper GI cancers

Date

20 Nov 2020

Session

Bristol Myers Squibb - The role of immuno-oncology in the evolving treatment landscapes of upper GI cancers

Topics

Immunotherapy

Tumour Site

Gastrointestinal Cancers

Presenters

Ka-On Lam

Authors

M. Ng1, K. Shitara2, C. Hsu3, K. Lam4

Author affiliations

  • 1 NCCS - National Cancer Centre Singapore, 169610 - Singapore/SG
  • 2 Department Of Gastrointestinal Oncology, National Cancer Center Hospital East, 277-8577 - Kashiwa/JP
  • 3 Department Of Medical Oncology, National Taiwan University Cancer Center, Taipei/TW
  • 4 Medical Oncology, The University of Hong Kong, Hong Kong/CN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Live Q&A

Presenter: Ka-On Lam

Session: Bristol Myers Squibb - The role of immuno-oncology in the evolving treatment landscapes of upper GI cancers

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.